Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    mbn-101
Previous Study | Return to List | Next Study

Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02436876
Recruitment Status : Completed
First Posted : May 7, 2015
Last Update Posted : July 2, 2020
Sponsor:
Collaborators:
University of Pennsylvania
University of California, San Francisco
Medpace, Inc.
Congressionally Directed Medical Research Programs
Information provided by (Responsible Party):
Microbion Corporation

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : July 26, 2018
Actual Study Completion Date : May 8, 2019
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 August 2, 2021
August 25, 2021